ADH5
Aliases:
This biomarker is also known as:- Alcohol dehydrogenase class-III
- formaldehyde dehydrogenase
- S-(hydroxymethyl)glutathione dehydrogenase
- alcohol dehydrogenase class-III
- Alcohol dehydrogenase class chi chain
- Alcohol dehydrogenase 5
- alcohol dehydrogenase class-3
- alcohol dehydrogenase 5 (class III), chi polypeptide
- GSNOR
- FDH
- ADH5
- Glutathione-dependent formaldehyde dehydrogenase
- EC 1.1.1.1,EC 1.1.1.-,EC 1.1.1.284
- FALDH
- alcohol dehydrogenase class chi chain
- ADHX
- glutathione-dependent formaldehyde dehydrogenase
- ADH-3
- alcohol dehydrogenase (class III), chi polypeptide
- GSH-FDH
Description…
From NCBI Gene: This gene encodes a member of the alcohol dehydrogenase family. Members of this family metabolize a wide variety of substrates, including ethanol, retinol, other aliphatic alcohols, hydroxysteroids, and lipid peroxidation products. The encoded protein forms a homodimer. It has virtually no activity for ethanol oxidation, but exhibits high activity for oxidation of long-chain primary alcohols and for oxidation of S-hydroxymethyl-glutathione, a spontaneous adduct between formaldehyde and glutathione. This enzyme is an important component of cellular metabolism for the elimination of formaldehyde, a potent irritant and sensitizing agent that causes lacrymation, rhinitis, pharyngitis, and contact dermatitis. The human genome contains several non-transcribed pseudogenes related to this gene. [provided by RefSeq, Oct 2008]
Datasets
There are no datasets associated with this biomarker.
Attributes
QA State: | Curated |
---|---|
Type: | Protein |
HGNC Name: | ADH5 |
The following organs have data associated with this biomarker…
Attributes
Phase: | 2 |
---|---|
QA State: | Under Review |
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.
- Multianalyte tests for the early detection of cancer: speedbumps and barriers.
- Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy.
- TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.